Renal and Extrarenal Actions of Klotho

Seminars in Nephrology

Volumn 33, Issue 2, 2013, Pages 118-129

  Hu, Ming Chang ^a,b   Kuro o, Makoto ^a,b   Moe, Orson W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Cardiac hypertrophy; Chronic kidney disease; Hyperparathyroidism; Klotho

Indexed keywords

CALCITRIOL; CARRIER PROTEIN; FIBROBLAST GROWTH FACTOR 23; ION CHANNEL; KLOTHO PROTEIN; PARATHYROID HORMONE; PROTEIN ROMK1; SODIUM PHOSPHATE COTRANSPORTER 2A; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 5;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; INTESTINE; KIDNEY; KIDNEY FIBROSIS; METABOLIC SYNDROME X; MINERAL METABOLISM; NONHUMAN; PARATHYROID GLAND; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL PROTECTION; SECONDARY HYPERPARATHYROIDISM; TISSUE REGENERATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ACUTE KIDNEY INJURY; ANIMALS; CARDIOMEGALY; GLUCURONIDASE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY; MICE; RATS; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION;

EID: 84875262394     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.12.013     Document Type: Article

References (89)

1. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51.
2. Kurosu H., Yamamoto M., Clark J.D., Pastor J.V., Nandi A., Gurnani P., et al. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833.
3. Kato Y., Arakawa E., Kinoshita S., Shirai A., Furuya A., Yamano K., et al. Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun 2000, 267:597-602.
4. Hu M.C., Shi M., Zhang J., Pastor J., Nakatani T., Lanske B., et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010, 24:3438-3450.
5. Forster R.E., Jurutka P.W., Hsieh J.C., Haussler C.A., Lowmiller C.L., Kaneko I., et al. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 2011, 414:557-562.
6. Mitobe M., Yoshida T., Sugiura H., Shirota S., Tsuchiya K., Nihei H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 2005, 101:e67-e74.
7. Chen C.D., Podvin S., Gillespie E., Leeman S.E., Abraham C.R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 2007, 104:19796-19801.
8. Imura A., Iwano A., Tohyama O., Tsuji Y., Nozaki K., Hashimoto N., et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 2004, 565:143-147.
9. Hu M.C., Shi M., Zhang J., Quinones H., Griffith C., Kuro-o M., et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011, 22:124-136.
10. Goetz R., Nakada Y., Hu M.C., Kurosu H., Wang L., Nakatani T., et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A 2010, 107:407-412.
11. Urakawa I., Yamazaki Y., Shimada T., Iijima K., Hasegawa H., Okawa K., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006, 444:770-774.
12. Kurosu H., Ogawa Y., Miyoshi M., Yamamoto M., Nandi A., Rosenblatt K.P., et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006, 281:6120-6123.
13. German D.C., Khobahy I., Pastor J., Kuro O.M., Liu X. Nuclear localization of Klotho in brain: an anti-aging protein. Neurobiol Aging 2012, 33:1483.e25-1483.e30.
14. Liu F., Wu S., Ren H., Gu J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 2011, 13:254-262.
15. Yoshida T., Fujimori T., Nabeshima Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 2002, 143:683-689.
16. Tsujikawa H., Kurotaki Y., Fujimori T., Fukuda K., Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003, 17:2393-2403.
17. Ohnishi M., Nakatani T., Lanske B., Razzaque M.S. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009, 75:1166-1172.
18. Ohnishi M., Razzaque M.S. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 2010, 24:3562-3571.
19. Segawa H., Yamanaka S., Ohno Y., Onitsuka A., Shiozawa K., Aranami F., et al. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 2007, 292:F769-F779.
20. Dermaku-Sopjani M., Sopjani M., Saxena A., Shojaiefard M., Bogatikov E., Alesutan I., et al. Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011, 28:251-258.
21. Cha S.K., Ortega B., Kurosu H., Rosenblatt K.P., Kuro O.M., Huang C.L. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A 2008, 105:9805-9810.
22. Chang Q., Hoefs S., van der Kemp A.W., Topala C.N., Bindels R.J., Hoenderop J.G. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005, 310:490-493.
23. Cha S.K., Hu M.C., Kurosu H., Kuro-o M., Moe O., Huang C.L. Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol 2009, 76:38-46.
24. Tohyama O., Imura A., Iwano A., Freund J.N., Henrissat B., Fujimori T., et al. Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides. J Biol Chem 2004, 279:9777-9784.
25. Moe O.W. PiT-2 coming out of the pits. Am J Physiol Renal Physiol 2009, 296:F689-F690.
26. Morishita K., Shirai A., Kubota M., Katakura Y., Nabeshima Y., Takeshige K., et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr 2001, 131:3182-3188.
27. Takeda E., Yamamoto H., Nashiki K., Sato T., Arai H., Taketani Y. Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 2004, 8:191-200.
28. Ben-Dov I.Z., Galitzer H., Lavi-Moshayoff V., Goetz R., Kuro-o M., Mohammadi M., et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007, 117:4003-4008.
29. Takeshita K., Fujimori T., Kurotaki Y., Honjo H., Tsujikawa H., Yasui K., et al. Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004, 109:1776-1782.
30. Canalejo R., Canalejo A., Martinez-Moreno J.M., Rodriguez-Ortiz M.E., Estepa J.C., Mendoza F.J., et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 2010, 21:1125-1135.
31. Tatsumi S., Segawa H., Morita K., Haga H., Kouda T., Yamamoto H., et al. Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 1998, 139:1692-1699.
32. Imura A., Tsuji Y., Murata M., Maeda R., Kubota K., Iwano A., et al. alpha-Klotho as a regulator of calcium homeostasis. Science 2007, 316:1615-1618.
33. Giral H., Caldas Y., Sutherland E., Wilson P., Breusegem S., Barry N., et al. Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 2009, 297:F1466-F1475.
34. Liu H., Fergusson M.M., Castilho R.M., Liu J., Cao L., Chen J., et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007, 317:803-806.
35. Maekawa Y., Ohishi M., Ikushima M., Yamamoto K., Yasuda O., Oguro R., et al. Klotho protein diminishes endothelial apoptosis and senescence via a mitogen-activated kinase pathway. Geriatr Gerontol Int 2011, 11:510-516.
36. de Oliveira R.M. Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett 2006, 580:5753-5758.
37. Dmitrieva N.I., Burg M.B. High NaCl promotes cellular senescence. Cell Cycle 2007, 6:3108-3113.
38. Nakano-Kurimoto R., Ikeda K., Uraoka M., Nakagawa Y., Yutaka K., Koide M., et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 2009, 297:H1673-H1684.
39. Haruna Y., Kashihara N., Satoh M., Tomita N., Namikoshi T., Sasaki T., et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A 2007, 104:2331-2336.
40. Sugiura H., Yoshida T., Mitobe M., Yoshida S., Shiohira S., Nitta K., et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant 2010, 25:60-68.
41. Saito Y., Yamagishi T., Nakamura T., Ohyama Y., Aizawa H., Suga T., et al. Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun 1998, 248:324-329.
42. Nagai R., Saito Y., Ohyama Y., Aizawa H., Suga T., Nakamura T., et al. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 2000, 57:738-746.
43. Shimada T., Takeshita Y., Murohara T., Sasaki K., Egami K., Shintani S., et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004, 110:1148-1155.
44. Fukino K., Suzuki T., Saito Y., Shindo T., Amaki T., Kurabayashi M., et al. Regulation of angiogenesis by the aging suppressor gene klotho. Biochem Biophys Res Commun 2002, 293:332-337.
45. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003, 112:1486-1494.
46. Takeshita K., Yamamoto K., Ito M., Kondo T., Matsushita T., Hirai M., et al. Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse. Semin Thromb Hemost 2002, 28:545-554.
47. Sugiura H., Yoshida T., Shiohira S., Kohei J., Mitobe M., Kurosu H., et al. Reduced klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol 2012, 302:F1252-F1264.
48. Doi S., Zou Y., Togao O., Pastor J.V., John G.B., Wang L., et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011, 286:8655-8665.
49. Cleland S.J. Cardiovascular risk in double diabetes mellitus-when two worlds collide. Nat Rev Endocrinol 2012, 8:476-485.
50. Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circ J 2012, 76:1066-1073.
51. Kurella M., Lo J.C., Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16:2134-2140.
52. Majumdar V., Christopher R. Association of exonic variants of Klotho with metabolic syndrome in Asian Indians. Clin Chim Acta 2011, 412:1116-1121.
53. Asai O., Nakatani K., Tanaka T., Sakan H., Imura A., Yoshimoto S., et al. Decreased renal alpha-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012, 81:539-547.
54. Zhao Y., Banerjee S., Dey N., LeJeune W.S., Sarkar P.S., Brobey R., et al. Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 2011, 60:1907-1916.
55. Aizawa H., Saito Y., Nakamura T., Inoue M., Imanari T., Ohyama Y., et al. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 1998, 249:865-871.
56. Yamagishi T., Saito Y., Nakamura T., Takeda S., Kanai H., Sumino H., et al. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors. Hypertens Res 2001, 24:705-709.
57. Wang Y., Sun Z. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 2009, 54:810-817.
58. Saito Y., Nakamura T., Ohyama Y., Suzuki T., Iida A., Shiraki-Iida T., et al. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 2000, 276:767-772.
59. Cheng M.F., Chen L.J., Cheng J.T. Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats. J Biomed Biotechnol 2010, 2010:513853.
60. Unger R.H. Klotho-induced insulin resistance: a blessing in disguise?. Nat Med 2006, 12:56-57.
61. Wang X., Liu X., Zhan Y., Lavallie E.R., Diblasio-Smith L., Collins-Racie L., et al. Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J Pharmacol Exp Ther 2010, 334:820-829.
62. Schumock G.T., Andress D.L., Marx S.E., Sterz R., Joyce A.T., Kalantar-Zadeh K. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 2009, 113:c54-c61.
63. Isakova T., Wahl P., Vargas G.S., Gutierrez O.M., Scialla J., Xie H., et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011, 79:1370-1378.
64. Hasegawa H., Nagano N., Urakawa I., Yamazaki Y., Iijima K., Fujita T., et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 2010, 78:975-980.
65. Shimamura Y., Hamada K., Inoue K., Ogata K., Ishihara M., Kagawa T., et al. Serum levels of soluble secreted alpha-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol 2012, 16:722-729.
66. Shimada T., Urakawa I., Isakova T., Yamazaki Y., Epstein M., Wesseling-Perry K., et al. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 2010, 95:578-585.
67. Kumata C., Mizobuchi M., Ogata H., Koiwa F., Nakazawa A., Kondo F., et al. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism. Am J Nephrol 2010, 31:230-238.
68. Komaba H., Goto S., Fujii H., Hamada Y., Kobayashi A., Shibuya K., et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010, 77:232-238.
69. Krajisnik T., Olauson H., Mirza M.A., Hellman P., Akerstrom G., Westin G., et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010, 78:1024-1032.
70. Galitzer H., Ben-Dov I.Z., Silver J., Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010, 77:211-218.
71. Hofman-Bang J., Martuseviciene G., Santini M.A., Olgaard K., Lewin E. Increased parathyroid expression of klotho in uremic rats. Kidney Int 2010, 78:1119-1127.
72. Ichikawa S., Imel E.A., Kreiter M.L., Yu X., Mackenzie D.S., Sorenson A.H., et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007, 117:2684-2691.
73. Nakatani T., Sarraj B., Ohnishi M., Densmore M.J., Taguchi T., Goetz R., et al. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J 2009, 23:433-441.
74. Tangri N., Alam A., Wooten E.C., Huggins G.S. Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort. Nephrol Dial Transplant 2011, 26:3998-4002.
75. Ikushima M., Rakugi H., Ishikawa K., Maekawa Y., Yamamoto K., Ohta J., et al. Anti-apoptotic and anti-senescence effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun 2006, 339:827-832.
76. Donate-Correa J., Mora-Fernandez C., Martinez-Sanz R., Muros-de-Fuentes M., Perez H., Meneses-Perez B., et al. Expression of FGF23/KLOTHO system in human vascular tissue. Int J Cardiol 2011, Epub ahead of print.
77. Lim K., Lu T.S., Molostvov G., Lee C., Lam F., Zehnder D., et al. Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF23. Circulation 2012, 125:2243-2255.
78. Yahata K., Mori K., Mukoyama M., Sugawara A., Suganami T., Makino H., et al. Regulation of stanniocalcin 1 and 2 expression in the kidney by klotho gene. Biochem Biophys Res Commun 2003, 310:128-134.
79. Takei Y., Yamamoto H., Sato T., Otani A., Kozai M., Masuda M., et al. Stanniocalcin 2 is associated with ectopic calcification in alpha-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells. Bone 2012, 50:998-1005.
80. Achinger S.G., Ayus J.C. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005, 95:S37-S42.
81. Faul C., Amaral A.P., Oskouei B., Hu M.C., Sloan A., Isakova T., et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011, 121:4393-4408.
82. Mirza M.A., Larsson A., Melhus H., Lind L., Larsson T.E. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009, 207:546-551.
83. Sugiura H., Yoshida T., Tsuchiya K., Mitobe M., Nishimura S., Shirota S., et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant 2005, 20:2636-2645.
84. Mitani H., Ishizaka N., Aizawa T., Ohno M., Usui S., Suzuki T., et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 2002, 39:838-843.
85. Hu M.C., Shi M., Zhang J., Quinones H., Kuro-o M., Moe O.W. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 2010, 78:1240-1251.
86. Zhang H., Li Y., Fan Y., Wu J., Zhao B., Guan Y., et al. Klotho is a target gene of PPAR-gamma. Kidney Int 2008, 74:732-739.
87. Narumiya H., Sasaki S., Kuwahara N., Irie H., Kusaba T., Kameyama H., et al. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc Res 2004, 64:331-336.
88. Yoon H.E., Ghee J.Y., Piao S., Song J.H., Han D.H., Kim S., et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 2011, 26:800-813.
89. Sugiura H., Tsuchiya K., Nitta K. Circulating levels of soluble alpha-Klotho in patients with chronic kidney disease. Clin Exp Nephrol 2011, 15:795-796.